Industry opposes genomic legislation [1]

Nature Biotechnology

Volumn 20, Issue 7, 2002, Pages 657-

  Merz, Jon F ^a   Leonard, Debra G B ^b   Kriss, Antigone G ^c   Cho, Mildred K ^b  

^a Center for Bioethics   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Finnegan Henderson Farabow Garrett and Dunner LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; ECONOMICS; GENETIC DISORDER; GENOME; HEALTH INSURANCE; HUMAN; LEGAL ASPECT; MASS SCREENING; NOTE; PATENT; UNITED STATES; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL PROTOCOL; LETTER; MEDICAL LITERATURE; MEDICAL RESEARCH; ORGANIZATION; PRIORITY JOURNAL;

BIOTECHNOLOGY; GENETIC DISEASES, INBORN; GENOME, HUMAN; HUMANS; INSURANCE, HEALTH; MASS SCREENING; PATENTS; UNITED STATES; HUMAN;

EID: 0036634343     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0702-657     Document Type: Letter

References (0)